These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition. Neal JM; Kunze KL; Levy RH; O'Reilly RA; Trager WF Drug Metab Dispos; 2003 Aug; 31(8):1043-8. PubMed ID: 12867493 [TBL] [Abstract][Full Text] [Related]
23. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients. McAleer SD; Foondun AS; Feely M; Chrystyn H Chirality; 1997; 9(1):13-6. PubMed ID: 9094197 [TBL] [Abstract][Full Text] [Related]
24. Warfarin dosage predictions assisted by the analog computer. Carter BL; Barr W; Rock W; Taylor JW Ther Drug Monit; 1988; 10(1):69-73. PubMed ID: 3376184 [TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Holford NH Clin Pharmacokinet; 1986; 11(6):483-504. PubMed ID: 3542339 [TBL] [Abstract][Full Text] [Related]
34. Prediction of maintenance warfarin dosage from initial patient response. Carter BL; Reinders TP; Hamilton RA Drug Intell Clin Pharm; 1983 Jan; 17(1):23-6. PubMed ID: 6825554 [TBL] [Abstract][Full Text] [Related]
35. Non-linear multicompartment model for drug binding by extracellular proteins with an application to warfarin. Julkunen RJ; Kekki M; Himberg JJ; Wahlström B Acta Pharmacol Toxicol (Copenh); 1976 Feb; 38(2):90-103. PubMed ID: 946381 [No Abstract] [Full Text] [Related]
36. Drug-gene interactions: inherent variability in drug maintenance dose requirements. Westervelt P; Cho K; Bright DR; Kisor DF P T; 2014 Sep; 39(9):630-7. PubMed ID: 25210416 [TBL] [Abstract][Full Text] [Related]
37. Warfarin maintenance dose Prediction for Patients undergoing heart valve replacement- a hybrid model with genetic algorithm and Back-Propagation neural network. Li Q; Tao H; Wang J; Zhou Q; Chen J; Qin WZ; Dong L; Fu B; Hou JL; Chen J; Zhang WH Sci Rep; 2018 Jun; 8(1):9712. PubMed ID: 29946101 [TBL] [Abstract][Full Text] [Related]
38. An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction. Carlquist JF; Horne BD; Mower C; Park J; Huntinghouse J; McKinney JT; Muhlestein JB; Anderson JL J Thromb Thrombolysis; 2010 Oct; 30(3):358-64. PubMed ID: 20499136 [TBL] [Abstract][Full Text] [Related]
39. Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing. Carlquist JF; McKinney JT; Nicholas ZP; Clark JL; Kahn SF; Horne BD; Muhlestein JB; May HT; Anderson JL J Thromb Thrombolysis; 2008 Aug; 26(1):1-7. PubMed ID: 17661181 [TBL] [Abstract][Full Text] [Related]